Ameriprise Financial Inc Rigel Pharmaceuticals Inc Transaction History

Ameriprise Financial Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.67 - $3.19 $249,576 - $1.19 Million	-372,502 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.22 - $3.45 $243,534 - $378,465	109,700 Added 41.74%	372,502 $1.11 Million
Q4 2021 Feb 14, 2022	BUY	$2.36 - $3.57 $620,212 - $938,203	262,802 New	262,802 $696,000
Q1 2020 May 15, 2020	SELL	$1.27 - $3.0 $93,764 - $221,490	-73,830 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$1.6 - $2.43 $118,128 - $179,406	73,830 New	73,830 $158,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.